DC Chemicals

All products / DC12661

CT1812
CAT. NO. DC12661

CT1812

Pack sizes and prices

Pack sizePrice
10 mg$400 USDRequest a quote / confirm availability →
25 mg$700 USDRequest a quote / confirm availability →
50 mg$1,200 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

Elayta (CT1812) is a novel allosteric antagonist of the sigma-2 receptor complex that prevents and displaces binding of Aβ oligomers to neurons. By stopping a key initiating event in Alzheimer's disease, this first-in–class drug candidate mitigates downstream synaptotoxicity and restores cognitive function in aged transgenic mouse models of Alzheimer's disease. CT1812 was well tolerated with single dose administration up to 1120 mg and with multiple dose administration up to 840 mg and 560 mg in healthy young and healthy elderly subjects, respectively. CT1812 is currently being studied in early phase 2 trials in patients with Alzheimer's disease.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC12661
Product nameCT1812
CAS1802632-22-9
Molecular formulaC24H33NO4S
Molecular weight431.588125944138
Purity>98%
SMILESCC(C)(C)Oc1cc(CCC(C)(C)N2Cc3ccc(S(C)(=O)=O)cc3C2)ccc1O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — CT1812 (DC12661)

Related research products

Browse newly added products